Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine + HAAG vs IA in newly diagnosed AML (<60 years)
NCT04087967Phase 3Unknown
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Apr 2019
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of decitabine in acute myeloid leukemia (AML), sponsored by First Affiliated Hospital of Soochow University. Status: unknown.
02
Drugs
decitabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT04087967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04087967.